Search the Newsreel

Avient Corporation Stock 12‑Month Price Target Raised to $48.12, Implies 27% Upside

Avient Corporation's average stock price target has increased to $48.12 from $47.5, based on estimates from 8 analysts, with forecasts ranging from $42 to $54 per share. This updated target suggests a potential upside of approximately 27% from the August 5 closing price. The …

FVR Stock Price and Chart — NYSE:FVR

This article provides a detailed overview of FrontView REIT, Inc. (FVR) stock, including its current price, historical performance, key financial metrics, and analyst ratings. It highlights the company's business model of acquiring and managing net-leased outparcel properties and offers answers to frequently asked questions …

Navient Corporation Stock 12‑Month Price Target Raised to $9.69, Implies 2% Upside

The average price target for Navient Corporation (NAVI) stock has increased from $9.61 to $9.69, according to estimates from 8 analysts, suggesting a 2% potential upside based on the Aug. 6 closing price. The target range for the stock is between $8 and $14 …

Earnings call transcript: Avient beats Q2 2026 estimates and lifts outlook

Earnings call transcript: Navient posts 45% EPS gain in Q2 2026 as stock hits high

Navient earnings beat by $0.10, revenue topped estimates

Navient (NAVI) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Navient (NAVI) reported Q2 2026 revenue of $120 million, an 8.4% year-over-year decline, missing the Zacks Consensus Estimate. However, its EPS of $0.29 surpassed the consensus estimate by 52.63%. The article also details how key financial metrics like net interest margin and core non-interest …

ABBV6474383 Bond Price and Chart — FINRA:ABBV6474383

This article provides details about the ABBV6474383 bond issued by AbbVie Inc. It lists key terms such as the coupon rate (5.45%), maturity date (September 15, 2038), and outstanding amount. The article also includes company information for AbbVie, Inc., describing it as a research-based …

Navient (NASDAQ:NAVI) Issues Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Navient (NASDAQ:NAVI) announced its quarterly earnings, reporting an EPS of $0.29, surpassing analyst expectations of $0.20 by $0.09. The company's revenue of $150 million also exceeded estimates. Following the announcement, Navient's shares rose by 4.7% to $9.49, and it maintains a quarterly dividend of …

FrontView REIT, Inc. Q2 2026: Revenue $18M, EPS $0.26— 10-Q Summary

BrightView Holdings (NYSE: BV) director adds 50,000 shares through trusts

BrightView Holdings (NYSE: BV) director William L. Cornog purchased 50,000 shares of common stock on August 6, 2026, through trusts for his children and a living trust. These transactions occurred at weighted-average prices of $11.25 and $11.24 per share, contributing to his indirect holdings. …

Analysts’ Top Industrial Goods Picks: BrightView Holdings (BV), BWX Technologies (BWXT)

Analysts have issued neutral ratings for BrightView Holdings (BV) and BWX Technologies (BWXT), indicating neither a bullish nor bearish stance. Goldman Sachs maintained a Hold rating on BrightView with a price target of $10.80, while Maxim Group maintained a Hold rating on BWX Technologies. …

Avient Corp (AVNT) (Q2 2026) Earnings Call Highlights: Record Margins and Raised Guidance ...

Avient Corp (AVNT) reported strong Q2 2026 earnings, exceeding expectations with an adjusted EPS of $0.96 and record adjusted EBITDA margins of 18.3%. The company saw significant organic sales growth, particularly in Asia, and raised its full-year guidance for adjusted EBITDA, EPS, and free …

Regenxbio Inc (RGNX) (Q2 2026) Earnings Call Highlights: Cash Runway Extended into Q4 2027 on ...

This article first appeared on GuruFocus. Cash Position: Ended Q2 2026 with cash, equivalents, and marketable securities of $106 million. Pro Forma Cash: More than $310 million after receiving a $100 million milestone payment from AbbVie and approximately $108 million in net proceeds from …

Avient (NYSE: AVNT) lifts H1 2026 earnings while reducing debt

Avient Corporation reported strong financial results for the first half of 2026, with sales increasing to $1,764.4 million and net income attributable to common shareholders rising significantly to $120.5 million. The company also reduced its total debt to $1,898.6 million through voluntary prepayments, while …

FrontView Q2 2026 slides: diversification drives growth amid skepticism

FrontView REIT (NASDAQ:FVR) delivered strong second-quarter 2026 results, raising its full-year AFFO per share guidance to $1.32-$1.34, despite a 4.06% stock decline post-earnings. The company emphasized its diversified portfolio, disciplined capital allocation, and strong operational efficiency, including a low dividend payout ratio and conservative …

Earnings call transcript: FrontView tops Q2 2026 EPS forecast, shares fall

FrontView (FVR) reported stronger-than-expected Q2 2026 adjusted EPS of $0.03, beating analyst forecasts for a loss of $0.04, with revenue at $18.01 million. Despite the earnings beat and raised full-year AFFO per share guidance, the stock fell 3.69% in premarket trading, suggesting investors were …

Avient Releases Q2 2026 Financial Results

Avient Corporation reported strong Q2 2026 financial results, surpassing Wall Street expectations with adjusted earnings of $0.96 per share and revenue of $917.0M. The specialty materials formulator saw organic sales growth of 4.3%, driven by its Color, Additives and Inks segment. The company also …

BrightView Holdings, Inc. Stock 12‑Month Price Target Cut to $16.35, Implies 25% Upside

BrightView Holdings, Inc. (BV) has seen its average 12-month price target reduced from $16.68 to $16.35 by 10 analysts, with individual forecasts ranging from $10 to $24 per share. Despite the cut, this updated target still suggests a potential upside of approximately 25% from …

Why Avient (AVNT) is a Great Dividend Stock Right Now

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus. Cash flow can come from bond …

FrontView REIT Q2 2026 Earnings Call Highlights

FrontView REIT reported strong Q2 2026 results, including a $200,000 sequential increase in base rent and a raised 2026 AFFO per share guidance to $1.32-$1.34. The company also raised $50.50 million through an ATM program and acquired 17 properties for $58.2 million, demonstrating active …

AVNT or AIQUY: Which Is the Better Value Stock Right Now?

Investors with an interest in Chemical - Diversified stocks have likely encountered both Avient (AVNT) and Air Liquide (AIQUY). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found …

Press Release: FrontView REIT Announces Second Quarter 2026 Results and Raises 2026 Net Investment and AFFO per Share Guidance

FrontView REIT announced its second-quarter 2026 results, reporting significant financial growth. The company reported a net income of $222.8 million and diluted earnings per share of $1.51, along with a 13.9% increase in Adjusted Funds From Operations (AFFO) per share to $1.39. Following these …

Riverview Bancorp Inc (RVSB) Insider Jon Girod Buys 1,000 Shares, Increasing Stake to 3,000 Shares

Jon Girod, an insider at Riverview Bancorp Inc (RVSB), recently purchased 1,000 shares, increasing his total stake to 3,000 shares. This transaction, valued at approximately $5,410, is part of a broader trend of significant insider buying at RVSB, with 14 insider buys and no …

Oppenheimer Adjusts PT on BrightView Holdings to $16 From $17, Maintains Outperform Rating

Oppenheimer has adjusted its price target for BrightView Holdings (BV) to $16 from the previous $17, while reiterating an Outperform rating on the stock. This update reflects a re-evaluation of the company's financial outlook by the analyst firm. The article also provides a company …

AbbVie Inc. (ABBV) Stock forecasts

Argus Research has raised its target price for AbbVie Inc. (ABBV) to $270, noting the company's status as a research-based biopharmaceutical firm spun off from Abbott Laboratories. AbbVie is a component of the S&P 500, with its shares currently trading at $244.93. The report …

Is Avient Corp (AVNT) Undervalued After Q2 Earnings Beat? GAAP E

Compared to Estimates, Avient (AVNT) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2026, Avient (AVNT) reported revenue of $917 million, up 5.8% over the same period last year. EPS came in at $0.96, compared to $0.80 in the year-ago quarter. The reported revenue represents a surprise of +2.43% over the Zacks …

Avient (NYSE:AVNT) Releases FY 2026 Earnings Guidance

Avient Corporation 2026 Q2 - Results - Earnings Call Presentation (NYSE:AVNT) 2026-08-06

Avient Corporation (NYSE:AVNT) has released its Q2 2026 earnings call presentation, reporting an EPS of $0.96, which beat estimates by $0.07. The company's revenue for the quarter was $917.00M, surpassing expectations by $19.51M and showing a 5.83% year-over-year increase. This presentation was published in …

Avient Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Avient Corporation announced its earnings results for the second quarter and six months ended June 30, 2026. For Q2 2026, the company reported sales of USD 917 million, up from USD 866.5 million in the prior year, and net income increased to USD 64.8 …

Avient (AVNT) Beats Q2 Earnings and Revenue Estimates

Avient (AVNT) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.8 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Avient Corp (AVNT) shows negative returns across 1-, 4- and 12-week spans

The Aug. 6 earnings date gives the specialty-polymer materials maker a near-term catalyst after a soft weekly tape.

REGENXBIO Reports Second Quarter 2026 Financial Results and Operational Highlights

RGX-202 BLA submission for Duchenne muscular dystrophy on track for Q3 2026 initiation, with potential accelerated approval in 2H 2027 Long-term surabgene lomparvovec (sura-vec, ABBV-RGX-314) data highlight durable safety and efficacy profile ahead of key catalyst Topline data from pivotal subretinal wet AMD studies, …

Earnings Flash (AVNT) Avient Corporation Reports Q2 Revenue $917.0M, vs. FactSet Est of $898.5M

Avient Corporation (AVNT) announced its second-quarter revenue reached $917.0 million, surpassing FactSet's estimate of $898.5 million. The company also posted Q2 adjusted EPS of $0.96 per share, exceeding FactSet's estimate of $0.89. Avient continues to maintain its quarterly dividend at $0.275 a share.

Avient Announces Second Quarter 2026 Results; Increases Full-Year Guidance

Second quarter sales grew 5.8% to $917 million, driven by 4.3% organic sales growth and 1.5% favorable foreign exchange, with organic growth in both business segments Second quarter GAAP EPS of $0.70 compared to $0.57 in the prior year quarter Second quarter adjusted EPS …